National Institute on Drug Abuse; Notice of Closed Meeting, 61017 [2020-21497]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 189 / Tuesday, September 29, 2020 / Notices
Public participants may also submit
written statements as further described
below. To submit written comments or
to request time for an oral comment at
the meeting, please register online by
12:00 p.m. ET on October 28, 2020.
Information about CHAC can be found
on the CHAC website at https://
www.cdc.gov/maso/facm/
facmCHACHSPT.html. Visit the meeting
information page for additional details
https://chacfall2020.org. Individuals
who plan to attend and need special
assistance or another reasonable
accommodation should notify Theresa
Jumento at the email address and phone
number listed above at least 10 business
days prior to the meeting.
Maria G. Button,
Director, Executive Secretariat.
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
jbell on DSKJLSW7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; NIDA
SEP for Career Development (K99/R00 and
K12 applications).
Date: November 4, 2020.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Sindhu Kizhakke
Madathil, Ph.D., Scientific Review Officer,
Office of Extramural Policy and Review,
Division of Extramural Research, National
Institute on Drug Abuse, NIH, 301 North
Stonestreet Avenue, 3 WFN 9th Floor, MSC
6021, Bethesda, MD 20892, (301) 827–5702,
sindhu.kizhakkemadathil@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
18:14 Sep 28, 2020
Jkt 250001
Dated: September 23, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–21497 Filed 9–28–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meetings
[FR Doc. 2020–20943 Filed 9–28–20; 8:45 am]
VerDate Sep<11>2014
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of
meetings of the President’s Cancer
Panel.
The meetings will be held as virtual
meetings and are open to the public.
Individuals who plan to view the virtual
meetings and need special assistance or
other reasonable accommodations to
view the meetings should notify the
Contact Person listed below in advance
of the meetings. The meetings can be
accessed by clicking on the following
link: https://nci.rev.vbrick.com/#/
webcasts/presidentscancerpanel.
Name of Committee: President’s Cancer
Panel.
Date: November 2, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: Improving Resilience and Equity
in Cancer Screening: Lessons from COVID–19
and Beyond (Day 1—Colorectal Cancer).
Place: National Cancer Institute, 31 Center
Drive, Building 31, Room 11A48, Rockville,
MD 20850, (Virtual Meeting).
Access to Meeting: https://
nci.rev.vbrick.com/#/webcasts/
presidentscancerpanel.
Contact Person: Maureen R. Johnson,
Ph.D., Executive Secretary, President’s
Cancer Panel, Special Assistant to the
Director, National Cancer Institute, NIH, 31
Center Drive, Room 11A48 MSC 2590,
Bethesda, MD 20892, 240–781–3327,
johnsonr@mail.nih.gov.
Name of Committee: President’s Cancer
Panel.
Date: November 4, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: Improving Resilience and Equity
in Cancer Screening: Lessons from COVID–19
and Beyond (Day 2—Colorectal Cancer).
Place: National Cancer Institute, 31 Center
Drive, Building 31, Room 11A48, Rockville,
MD 20850 (Virtual Meeting).
Access to Meeting: https://
nci.rev.vbrick.com/#/webcasts/
presidentscancerpanel.
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
61017
Contact Person: Maureen R. Johnson,
Ph.D., Executive Secretary, President’s
Cancer Panel, Special Assistant to the
Director, National Cancer Institute, NIH, 31
Center Drive, Room 11A48 MSC 2590,
Bethesda, MD 20892, 240–781–3327,
johnsonr@mail.nih.gov.
Name of Committee: President’s Cancer
Panel.
Date: November 9, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: Improving Resilience and Equity
in Cancer Screening: Lessons from COVID–19
and Beyond (Day 1—Cervical Cancer).
Place: National Cancer Institute, 31 Center
Drive, Building 31, Room 11A48, Rockville,
MD 20850, (Virtual Meeting).
Access to Meeting: https://
nci.rev.vbrick.com/#/webcasts/
presidentscancerpanel.
Contact Person: Maureen R. Johnson,
Ph.D., Executive Secretary, President’s
Cancer Panel, Special Assistant to the
Director, National Cancer Institute, NIH, 31
Center Drive, Room 11A48 MSC 2590,
Bethesda, MD 20892, 240–781–3327,
johnsonr@mail.nih.gov.
Name of Committee: President’s Cancer
Panel.
Date: November 10, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: Improving Resilience and Equity
in Cancer Screening: Lessons from COVID–19
and Beyond (Day 2—Cervical Cancer).
Place: National Cancer Institute, 31 Center
Drive, Building 31, Room 11A48, Rockville,
MD, 20850 (Virtual Meeting).
Access to Meeting: https://
nci.rev.vbrick.com/#/webcasts/
presidentscancerpanel.
Contact Person: Maureen R. Johnson,
Ph.D., Executive Secretary, President’s
Cancer Panel, Special Assistant to the
Director, National Cancer Institute, NIH, 31
Center Drive, Room 11A48 MSC 2590
Bethesda, MD 20892, 240–781–3327,
johnsonr@mail.nih.gov.
Name of Committee: President’s Cancer
Panel.
Date: November 16, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: Improving Resilience and Equity
in Cancer Screening: Lessons from COVID–19
and Beyond (Day 1—Breast Cancer).
Place: National Cancer Institute, 31 Center
Drive, Building 31, Room 11A48, Rockville,
MD 20850, (Virtual Meeting).
Access to Meeting: https://
nci.rev.vbrick.com/#/webcasts/
presidentscancerpanel.
Contact Person: Maureen R. Johnson,
Ph.D., Executive Secretary, President’s
Cancer Panel, Special Assistant to the
Director, National Cancer Institute, NIH, 31
Center Drive, Room 11A48, MSC 2590,
Bethesda, MD 20892, 240–781–3327,
johnsonr@mail.nih.gov.
Name of Committee: President’s Cancer
Panel.
Date: November 18, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: Improving Resilience and Equity
in Cancer Screening: Lessons from COVID–19
and Beyond (Day 2—Breast Cancer).
E:\FR\FM\29SEN1.SGM
29SEN1
]]>Agencies
[Federal Register Volume 85, Number 189 (Tuesday, September 29, 2020)]
[Notices]
[Page 61017]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-21497]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; NIDA SEP for Career Development (K99/R00 and K12
applications).
Date: November 4, 2020.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Sindhu Kizhakke Madathil, Ph.D., Scientific
Review Officer, Office of Extramural Policy and Review, Division of
Extramural Research, National Institute on Drug Abuse, NIH, 301
North Stonestreet Avenue, 3 WFN 9th Floor, MSC 6021, Bethesda, MD
20892, (301) 827-5702, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
Abuse Scientist Development Award for Clinicians, Scientist
Development Awards, and Research Scientist Awards; 93.278, Drug
Abuse National Research Service Awards for Research Training;
93.279, Drug Abuse and Addiction Research Programs, National
Institutes of Health, HHS)
Dated: September 23, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-21497 Filed 9-28-20; 8:45 am]
BILLING CODE 4140-01-P
